InflaRx NV (IFRX)

1.32 -0.12 (-8.33%) USD  |  NASDAQ  |  Oct 16, 16:00
1.32 0.00 (0.00%) After-Hours: 19:11
More

InflaRx Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Operating Expenses (% of Quarterly Revenues) Data

View and export this data back to 2023. Start Trial.
Date Value
September 30, 2025 --
June 30, 2025 --
September 30, 2024 --
June 30, 2024 --
Date Value
March 31, 2024 --
December 31, 2023 --
September 30, 2023 --

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
MediGene AG --
BioNTech SE Upgrade
Immatics NV Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --